Biofil Chemicals and Pharmaceuticals Ltd
Fri 22/05/2026,15:45:8 | NSE : BIOFILCHEM
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 31.99
Previous Close
₹ 31.55
Volume
3728
Mkt Cap ( Rs. Cr)
₹51.70
High
₹ 32.25
Low
₹ 31.24
52 Week High
₹ 57.19
52 Week Low
₹ 25.60
Book Value Per Share
₹ 13.14
Dividend Yield
0.00
Face Value
₹ 10.00
What’s Your Call?
Collective community sentiment on Biofil Chemicals and Pharmaceuticals Ltd
Your Vote -
Buy
39.06%
Hold
7.81%
Sell
53.13%
39.06%
64 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
NaN%
Sell Order Quantity
NaN%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Biofil Chemicals and Pharmaceuticals Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Biofil Chem.&Pharma. - Board Meeting Intimation for Meeting Of Board Of The Directors (Serial No.01/2026-27) Of The Company S
-
Biofil Chem.&Pharma. - Disclosure under SEBI Takeover Regulations
-
Biofil Chem.&Pharma. - Updates
-
Biofil Chem.&Pharma. - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulatio
-
Biofil Chem.&Pharma. - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
-
Biofil Chem.&Pharma. has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026
-
Biofil Chem.&Pharma. - Copy of Newspaper Publication
-
Biofil Chem.&Pharma. - Updates
-
Biofil Chem.&Pharma. - Intimation Regarding SEBI Circular Dated January 30, 2026 - Ease Of Doing Investment - Special Window
-
Biofil Chem.&Pharma. - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Biofil Chem.&Pharma. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Biofil Chem.&Pharma. - Trading Window
Key fundamentals
Evaluate the intrinsic value of Biofil Chemicals and Pharmaceuticals Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 19.2527 | 18.6417 | 17.8268 | 17.3024 | 16.5589 |
| Liabilities | 19.2527 | 18.6417 | 17.8268 | 17.3024 | 16.5589 |
| Equity | 16.2738 | 16.2738 | 16.2738 | 16.2738 | 16.2738 |
| Gross Profit | 0.8474 | 0.8165 | 1.1676 | 1.3327 | 1.5991 |
| Net Profit | 0.5577 | 0.7092 | 0.5604 | 0.6984 | 1.2414 |
| Cash From Operating Activities | -1.9237 | 2.3937 | -0.1118 | -0.2199 | 1.1109 |
| NPM(%) | 1.66 | 1.77 | 1.86 | 3.12 | 3.47 |
| Revenue | 33.4022 | 40.0353 | 30.0352 | 22.3823 | 35.7504 |
| Expenses | 32.5548 | 39.2188 | 28.8676 | 21.0496 | 34.1513 |
| ROE(%) | 2.6 | 3.31 | 2.62 | 3.26 | 5.8 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Biofil Chemicals and Pharmaceuticals Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 705.80 | -0.07 | 0.00 | 17.95 | -26.19 | 0.71 |
| Lotus Eye Hospital and Institute Ltd | 109.19 | 1.26 | 352.23 | 65.40 | 3.55 | 0.00 |
| Vaishali Pharma Ltd | 7.00 | 0.14 | 0.00 | 410.30 | 3.13 | 0.00 |
| Astec Lifesciences Ltd | 771.80 | 4.77 | 0.00 | 61.68 | -363.15 | 0.00 |
Company Info
BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED was incorporated on 4th January, 1985 as Private Limited company for manufacturing of pharmaceutical products and subsequently converted into Public Limited Company on 28th May, 1992. The company was dormant and there was no business activity till the financial year 1992-93. The company has come out with its first public issue in Oct., 1993 to set up a unit to manufacture formulation based pharmaceutical products. The Company commenced commercial production in its existing formulation division with effect from September 25th 1993. Presently, the Company is engaged in manufacturing of range of formulations in the form of Injectables, Eye Drops, Dry Syrups/ Powders, Capsules etc. The company has been in successful operation for the last two years. 2011 -Registered office of the Company's Registrar and share transfer agent M/s. Ankit Consultancy Private Ltd. have been shifted to Ankit Consultancy Private Ltd.
BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED was incorporated on 4th January, 1985 as Private Limited company for manufacturing of pharmaceutical products and subsequently converted into Public Limited Company on 28th May, 1992. The company was dormant and there was no business activity till the financial year 1992-93. The company has come out with its first public issue in Oct., 1993 to set up a unit to manufacture formulation based pharmaceutical products. The Company commenced commercial production in its existing formulation division with effect from September 25th 1993. Presently, the Company is engaged in manufacturing of range of formulations in the form of Injectables, Eye Drops, Dry Syrups/ Powders, Capsules etc. The company has been in successful operation for the last two years. 2011 -Registered office of the Company's Registrar and share transfer agent M/s. Ankit Consultancy Private Ltd. have been shifted to Ankit Consultancy Private Ltd.
Read More
Parent Organisation
Biofil Chemicals & Pharmaceuticals Ltd.
Founded
04/01/1985
Managing Director
Mr.Ketan Shah
NSE Symbol
BIOFILCHEMEQ
FAQ
The current price of Biofil Chemicals and Pharmaceuticals Ltd is ₹ 31.77.
The 52-week high for Biofil Chemicals and Pharmaceuticals Ltd is ₹ 32.25 and the 52-week low is ₹ 31.24.
The market capitalization of Biofil Chemicals and Pharmaceuticals Ltd is currently ₹ 51.70. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Biofil Chemicals and Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Biofil Chemicals and Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Biofil Chemicals and Pharmaceuticals Ltd shares.
The CEO of Biofil Chemicals and Pharmaceuticals Ltd is Mr.Ketan Shah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
